HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).

AbstractBACKGROUND:
The consumption of sweet beverages has been associated with greater risk of type 2 diabetes and obesity, which may be involved in the development of pancreatic cancer. Therefore, it has been hypothesized that sweet beverages may increase pancreatic cancer risk as well.
OBJECTIVE:
We examined the association between sweet-beverage consumption (including total, sugar-sweetened, and artificially sweetened soft drink and juice and nectar consumption) and pancreatic cancer risk.
DESIGN:
The study was conducted within the European Prospective Investigation into Cancer and Nutrition cohort. A total of 477,199 participants (70.2% women) with a mean age of 51 y at baseline were included, and 865 exocrine pancreatic cancers were diagnosed after a median follow-up of 11.60 y (IQR: 10.10-12.60 y). Sweet-beverage consumption was assessed with the use of validated dietary questionnaires at baseline. HRs and 95% CIs were obtained with the use of multivariable Cox regression models that were stratified by age, sex, and center and adjusted for educational level, physical activity, smoking status, and alcohol consumption. Associations with total soft-drink consumption were adjusted for juice and nectar consumption and vice versa.
RESULTS:
Total soft-drink consumption (HR per 100 g/d: 1.03; 95% CI: 0.99, 1.07), sugar-sweetened soft-drink consumption (HR per 100 g/d: 1.02; 95% CI: 0.97, 1.08), and artificially sweetened soft-drink consumption (HR per 100 g/d: 1.04; 95% CI: 0.98, 1.10) were not associated with pancreatic cancer risk. Juice and nectar consumption was inversely associated with pancreatic cancer risk (HR per 100 g/d: 0.91; 95% CI: 0.84, 0.99); this association remained statistically significant after adjustment for body size, type 2 diabetes, and energy intake.
CONCLUSIONS:
Soft-drink consumption does not seem to be associated with pancreatic cancer risk. Juice and nectar consumption might be associated with a modest decreased pancreatic cancer risk. Additional studies with specific information on juice and nectar subtypes are warranted to clarify these results.
AuthorsEva M Navarrete-Muñoz, Petra A Wark, Dora Romaguera, Nirmala Bhoo-Pathy, Dominique Michaud, Esther Molina-Montes, Anne Tjønneland, Anja Olsen, Kim Overvad, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Guy Fagherazzi, Verena A Katzke, Tilman Kühn, Annika Steffen, Antonia Trichopoulou, Eleni Klinaki, Eleni-Maria Papatesta, Giovanna Masala, Vittorio Krogh, Rosario Tumino, Alessio Naccarati, Amalia Mattiello, Petra H Peeters, Charlotta Rylander, Christine L Parr, Guri Skeie, Elisabete Weiderpass, J Ramón Quirós, Eric J Duell, Miren Dorronsoro, José María Huerta, Eva Ardanaz, Nick Wareham, Kay-Tee Khaw, Ruth C Travis, Tim Key, Magdalena Stepien, Heinz Freisling, Elio Riboli, H Bas Bueno-de-Mesquita
JournalThe American journal of clinical nutrition (Am J Clin Nutr) Vol. 104 Issue 3 Pg. 760-8 (Sep 2016) ISSN: 1938-3207 [Electronic] United States
PMID27510540 (Publication Type: Journal Article, Multicenter Study)
Copyright© 2016 American Society for Nutrition.
Chemical References
  • Dietary Carbohydrates
  • Sweetening Agents
Topics
  • Adenocarcinoma (epidemiology, etiology, mortality, prevention & control)
  • Beverages (adverse effects, analysis)
  • Carbonated Beverages (adverse effects, analysis)
  • Cohort Studies
  • Dietary Carbohydrates (adverse effects, analysis)
  • Europe (epidemiology)
  • Female
  • Follow-Up Studies
  • Fruit and Vegetable Juices (adverse effects, analysis)
  • Functional Food (adverse effects, analysis)
  • Humans
  • Incidence
  • Male
  • Pancreatic Neoplasms (epidemiology, etiology, mortality, prevention & control)
  • Prevalence
  • Proportional Hazards Models
  • Prospective Studies
  • Registries
  • Risk Factors
  • Self Report
  • Sweetening Agents (adverse effects, analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: